Did Johnson & Johnson’s Shampoo Fail A Quality Test By The Indian Organization?

By John Heerdink LinkedIn

Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services.

A Reuters story reported that a quality test conducted by The Rajasthan Drugs Control Organisation, India on J&J shampoo concluded that formaldehyde, a harmful Ingredient was found in two batches of the shampoo. However, J&J refused to accept the allegation and assured that their products are free from any harmful chemicals and are safe for use.

As reported, the spokesperson for J&J stated “We unequivocally maintain that our products are safe and our assurance process is amongst the most rigorous in the world,” the J&J spokeswoman said, adding that the company has contested the interim test results of the government analysis that were based on “unknown and unspecified methods”.

To learn more about Johnson & Johnson (JNJ) and to continue to track its progress visit the Vista Partners Johnson & Johnson Coverage Page.

Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.

Stay Informed! Stay Competitive! Join us at Vista Partners! It’s FREE to receive email updates.

J&J baby shampoo samples fail Indian quality test; company rejects findings

Johnson & Johnson’s baby shampoo samples failed quality tests conducted by the northwestern Indian state of Rajasthan, according to a public notice from the state’s drugs watchdog, findings that were rejected by the U.S. drugmaker. This comes just a few months after Indian authorities launched…

finance.yahoo.com

Read Full Article


YOUR GUIDE TO STAYING INFORMED IN THE MARKETS

Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us